PGK1 as an immune target in Kawasaki disease
Author:
Affiliation:
1. 112 Laboratory, School of Chemistry and Biological Engineering, University of Science and Technology Beijing, Beijing, China
2. Department of Pediatrics, Beijing Children's Hospital Affiliated to Capital Medical University, Beijing, China
Abstract
Funder
National S&T Major Project of China
National Natural Science Foundation of China
S&T
Publisher
Oxford University Press (OUP)
Subject
Immunology,Immunology and Allergy
Link
https://academic.oup.com/cei/article-pdf/194/3/371/41645958/cei13204.pdf
Reference26 articles.
1. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children;Kawasaki;Arerugi,1967
2. Diagnosis and therapy of Kawasaki disease in children;Dajani;Circulation,1993
3. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients;Kato;Circulation,1996
4. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, council on cardiovascular disease in the young, American Heart Association;Newburger;Pediatrics,2004
5. Increased serum levels of vascular endothelial growth factor in Kawasaki disease;Maeno;Pediatr Res,1998
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Proteomics approach for biomarker discovery in Kawasaki disease;Expert Review of Clinical Immunology;2024-08-02
2. PGK1 modulates balance between pro- and anti-inflammatory cytokines by interacting with ITI-H4;Biomedicine & Pharmacotherapy;2023-05
3. Upregulated Expression of IL2RB Causes Disorder of Immune Microenvironment in Patients with Kawasaki Disease;BioMed Research International;2022-07-25
4. The basic functions of phosphoglycerate kinase 1 and its roles in cancer and other diseases;European Journal of Pharmacology;2022-04
5. A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better?;Cardiovascular Therapeutics;2021-06-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3